Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm.

Efficacy, Safety and Satisfaction of the New Pen Needle 33G x 4 mm 33G x 4 mm: Cross-over Randomized Controlled Clinical Trial. Studio AGO 01

During the last years, even more little needles are used for the injection of sub cutaneous insulin, for the diabetes therapy.

The aim of this study is to evaluate the non inferiority of a new needle, smaller than another needle, in terms of hematic levels od fructosamine, an indicator of glycemic control.

Inclusion Criteria:

• patients with type 1 or type 2 diabetes
• both males and females
• age >=18 anni
• insulin treatment from at least 6 months
• signed informed consent

Exclusion Criteria:

• pregnancy
• incapacity for filling in the questionnaires
• every illness or condition that, according to the investigator, could interfere with the study